Dr. Mulvagh is Professor of Medicine at Dalhousie University, and Co-director of the Women’s Heart Health Clinic at the Maritime Heart Center, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. After a 26 year career at Mayo Clinic, where she was Director of the Women’s Heart Clinic, she was awarded Professor Emeritus. She is a clinical and investigative cardiologist recognized internationally for her research and education focused on contrast echocardiography, including myocardial perfusion imaging and detection of early atherosclerosis using CEUS. During her career at Mayo Clinic, she was the principal investigator for numerous preclinical and clinical trials of contrast agents. Dr. Mulvagh chaired the initial and subsequent consensus documents for the cardiovascular applications of CEUS, and guided their evolution over the last several decades to our current American Society of Echocardiography (ASE) Guidelines. She has been on the Board of Directors and chaired numerous committees for the ASE, and has been on the editorial board of many cardiology journals. She has well over 100 peer-reviewed publications addressing investigative frontiers in echocardiography, and women and heart disease.
The information, references and opinions provided on this website do not constitute the offering of medical advice or create a physician-patient relationship between any one or more of (a) the International Contrast Ultrasound Society (ICUS), its directors and members, and the contributors to this website, and (b) you, your patients, and any other party. ICUS makes no express or implied warranties regarding the accuracy or completeness of the information, references and opinions on this website, and ICUS shall not be liable to you, your patients, or anyone else with respect to any medical decision made, or any action taken or not taken, in direct or indirect reliance on this information.